Filter byLast updatedSelectAfterBeforeFrom - ToDateEnd DateCategoryHumanTopicCOVID-19MedicinesData on medicinesAdvanced therapiesAntimicrobial resistanceBiologicalsBiosimilarsBrexitCareersClinical trialsCompassionate useCompliance and inspectionsCorporateEarly accessFeesGeneric and hybrid medicinesGovernanceInnovationMaximum residue limitMedication errorMedicines for use outside the EUMedicine shortagesMpoxPaediatricsParallel distributionPharmacovigilanceProcurementProduct informationQuality of medicinesRare diseasesReferralsRegulatory and procedural guidanceResearch and developmentScientific adviceScientific guidelinesSMEVaccinesVeterinary limited marketsDiseases areaCancerImmune-system diseasesViral diseasesCardiovascular diseasesDiabetesHIV and AIDSNeurodegenerative diseasesTreatment of human immunodeficiency virus type 1 (HIV-1) infectionResponsible bodyCHMPCATCMDhCOMPCVMPHMPCManagement BoardPDCOPRACPatient safetyYesFiltersResults (5) EvusheldSort byLast update date (new to old)Last update date (old to new)A-ZZ-AETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-29 December 2022NewsHumanCOVID-19MedicinesMeeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 202222 September 2022NewsHumanCOVID-19MedicinesMeeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 202225 March 2022NewsHumanCOVID-19MedicinesEMA recommends authorisation of COVID-19 medicine Evusheld24 March 2022NewsHumanCOVID-19Data on medicinesEMA starts rolling review of Evusheld (tixagevimab and cilgavimab)14 October 2021NewsHumanCOVID-19Medicines
ETF warns that monoclonal antibodies may not be effective against emerging strains of SARS-CoV-29 December 2022NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 202222 September 2022NewsHumanCOVID-19Medicines
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 21-24 March 202225 March 2022NewsHumanCOVID-19Medicines
EMA recommends authorisation of COVID-19 medicine Evusheld24 March 2022NewsHumanCOVID-19Data on medicines
EMA starts rolling review of Evusheld (tixagevimab and cilgavimab)14 October 2021NewsHumanCOVID-19Medicines